Efficacy of Bilhvax in Association With Praziquantel for Prevention of Clinical Recurrences of Schistosoma Haematobium

NCT00870649 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

250

Enrollment

OTHER_GOV

Sponsor class

Conditions

Urinary Schistosomiasis
Schistosoma Haematobium

Interventions

BIOLOGICAL: Bilhvax vaccine (Sh28GST)
BIOLOGICAL: placebo

Sponsor

Institut National de la Santé Et de la Recherche Médicale, France